Concomitant active tuberculosis prolongs survival in non-small cell lung cancer: A study in a tuberculosis-endemic country

Chih Hsi Kuo, Chun Yu Lo, Fu Tsai Chung, Kang Yun Lee, Shu Min Lin, Chun Hua Wang, Chih Chen Heh, Hao Cheng Chen, Han Pin Kuo

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Background: Adjuvant tumor cell vaccine with chemotherapy against non-small cell lung cancer (NSCLC) shows limited clinical response. Whether it provokes effective cellular immunity in tumor microenvironment is questionable. Concomitant active tuberculosis in NSCLC (TBLC) resembles locoregional immunotherapy of tumor cell vaccine; thus, maximally enriches effective anti-tumor immunity. This study compares the survival and immunological cell profile in TBLC over NSCLC alone. Methods: Retrospective review of NSCLC patients within 1-year-period of 2007 and follow-up till 2010. Results: A total 276 NSCLC patients were included. The median survival of TBLC is longer than those of NSCLC alone (11.6 vs. 8.8 month, p

Original languageEnglish
Article numbere33226
JournalPLoS One
Volume7
Issue number3
DOIs
Publication statusPublished - Mar 16 2012
Externally publishedYes

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Fingerprint Dive into the research topics of 'Concomitant active tuberculosis prolongs survival in non-small cell lung cancer: A study in a tuberculosis-endemic country'. Together they form a unique fingerprint.

  • Cite this